The development of diabetic cardiomyopathy can be triggered by the metabolites of gut microbiota, which control inflammation, insulin resistance, autophagy, oxidative stress, and apoptosis (Yuan et al. 2022). The gene discussed is INS; the disease is diabetic cardiomyopathy.